About Us

---

In response to the NIH Biosafety and Biosecurity Policy, the minuters of the most recent meeting of Virtus Therapeutics Biosafety Committee Meeting, convened on January 23, 2025, may be found here.

The NIH requires that all "Recipient Institutions" maintain an up-to-date, written, enforced policy on financial conflicts of interest that complies with the NIH regulations. Virtus Therapeutics policy is available here.